Paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN): a randomised, double-blind, phase 3 trialResearch in context

Summary: Background: Paramedics frequently administer analgesic medications for pain following trauma. Morphine is the most commonly administered strong analgesic. However, it may not be the best option as it may lower blood pressure, depress respiration and there is a risk of dependency. Ketamine...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael A. Smyth, Hannah Noordali, Kath Starr, Joyce Yeung, Ranjit Lall, Felix Michelet, Gordon Fuller, Stavros Petrou, Alison Walker, Zoe Green, Rebecca McLaren, Elisha Miller, Duncan Buckley, Gavin D. Perkins
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:The Lancet Regional Health. Europe
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666776225000572
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849733678563852288
author Michael A. Smyth
Hannah Noordali
Kath Starr
Joyce Yeung
Ranjit Lall
Felix Michelet
Gordon Fuller
Stavros Petrou
Alison Walker
Zoe Green
Rebecca McLaren
Elisha Miller
Duncan Buckley
Gavin D. Perkins
author_facet Michael A. Smyth
Hannah Noordali
Kath Starr
Joyce Yeung
Ranjit Lall
Felix Michelet
Gordon Fuller
Stavros Petrou
Alison Walker
Zoe Green
Rebecca McLaren
Elisha Miller
Duncan Buckley
Gavin D. Perkins
author_sort Michael A. Smyth
collection DOAJ
description Summary: Background: Paramedics frequently administer analgesic medications for pain following trauma. Morphine is the most commonly administered strong analgesic. However, it may not be the best option as it may lower blood pressure, depress respiration and there is a risk of dependency. Ketamine might be a better option due to speed of onset and favourable side-effect profile. We sought to compare clinical effectiveness of paramedic administered ketamine and morphine in patients with severe pain following trauma. Methods: PACKMaN was a double-blinded, randomised controlled, superiority trial, conducted in two regional ambulance services in the UK. Eligible patients were 16 years of age or over, had an acute injury, and articulated a pain score of 7 or greater on a 0–10 numeric rating score (NRS). We excluded pregnant patients, prisoners, those unable to articulate a pain score and anyone lacking capacity. The randomisation list prepared by the study programmer, utilised a permuted, unstratified, block randomisation system (variable size blocks) to achieve an overall ratio of 1:1 control (morphine): intervention (ketamine). Treatment packs were identical in appearance, apart from their unique sequential number. Individual participant randomisation occurred when the attending paramedic opened the treatment pack. The maximum available dose of morphine was 20 mg while the maximum available dose of ketamine was 30 mg. The treating paramedic administered the trial drug slowly, in regular small aliquots, via the intravenous (or intraosseous) route, titrating treatment until the patient reported adequate analgesia or requested that treatment stop due to undesired side effects. Timing of drug administration was not prespecified. The primary outcome was the Sum of Pain Intensity Difference (SPID) score on arrival to the hospital, calculated using patient reported NRS scores. Analysis was performed on an intention to treat basis. PACKMaN is registered with the International Clinical Trials Registry (ISRCTN14124474). Findings: PACKMaN recruited its first patient on 10/11/2021 and achieved its recruitment target on 16/05/2023. We randomised 449 participants: 219 (49%) received ketamine and 230 (51%) received morphine. The SPID score was 3.5 (SD 2.8) for ketamine and 3.4 (SD 3.0) for morphine. We found no significant difference in efficacy between drugs (adjusted mean difference 0.1, 95%CI −0.4 to 0.6, p = 0.74). There was no significant difference in the incidence of serious adverse events [4 (2%) ketamine; 8 (3%) morphine]. There were no treatment related deaths. Interpretation: Ketamine did not provide superior analgesia than morphine when used by paramedics to treat acute severe trauma pain. Unexpected adverse events occurred infrequently. Despite analgesia, many patients still experienced pain on arrival at hospital, highlighting the need for further research. Funding: PACKMaN was funded by the National Institute for Health and Care Research.
format Article
id doaj-art-933ef6259f3e446e9b68481ccf9cda93
institution DOAJ
issn 2666-7762
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series The Lancet Regional Health. Europe
spelling doaj-art-933ef6259f3e446e9b68481ccf9cda932025-08-20T03:07:58ZengElsevierThe Lancet Regional Health. Europe2666-77622025-06-015310126510.1016/j.lanepe.2025.101265Paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN): a randomised, double-blind, phase 3 trialResearch in contextMichael A. Smyth0Hannah Noordali1Kath Starr2Joyce Yeung3Ranjit Lall4Felix Michelet5Gordon Fuller6Stavros Petrou7Alison Walker8Zoe Green9Rebecca McLaren10Elisha Miller11Duncan Buckley12Gavin D. Perkins13University of Warwick, Gibbett Hill Road, Coventry CV4 7 AL, UK; University Hospital Coventry and Warwickshire NHS Trust, Clifford Bridge Road, Coventry CV2 2DX, UK; Corresponding author. Emergency and Critical Care Medicine, University of Warwick, UK.University of Warwick, Gibbett Hill Road, Coventry CV4 7 AL, UKUniversity of Warwick, Gibbett Hill Road, Coventry CV4 7 AL, UKUniversity of Warwick, Gibbett Hill Road, Coventry CV4 7 AL, UK; University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Birmingham B15 2GW, UKUniversity of Warwick, Gibbett Hill Road, Coventry CV4 7 AL, UKUniversity of Warwick, Gibbett Hill Road, Coventry CV4 7 AL, UKPopulation Health, School of Medicine and Population Health, University of Sheffield, 30 Regent Street, Sheffield S1 4DA, UKNuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Woodstock Road, Oxford OX2 6GG, UKWest Midlands Ambulance Service University NHS Foundation Trust, Waterfront Business Park, Dudley DY5 1LX, UKWest Midlands Ambulance Service University NHS Foundation Trust, Waterfront Business Park, Dudley DY5 1LX, UKYorkshire Ambulance Service NHS Foundation Trust, Wakefield 41 Business Park, Brindley Way, Wakefield, West Yorkshire WF2 0XQ, UKNIHR Academy, 21 Queen Street, Leeds, West Yorkshire LS1 2TW, UKUniversity of Warwick, Gibbett Hill Road, Coventry CV4 7 AL, UKUniversity of Warwick, Gibbett Hill Road, Coventry CV4 7 AL, UK; University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Birmingham B15 2GW, UKSummary: Background: Paramedics frequently administer analgesic medications for pain following trauma. Morphine is the most commonly administered strong analgesic. However, it may not be the best option as it may lower blood pressure, depress respiration and there is a risk of dependency. Ketamine might be a better option due to speed of onset and favourable side-effect profile. We sought to compare clinical effectiveness of paramedic administered ketamine and morphine in patients with severe pain following trauma. Methods: PACKMaN was a double-blinded, randomised controlled, superiority trial, conducted in two regional ambulance services in the UK. Eligible patients were 16 years of age or over, had an acute injury, and articulated a pain score of 7 or greater on a 0–10 numeric rating score (NRS). We excluded pregnant patients, prisoners, those unable to articulate a pain score and anyone lacking capacity. The randomisation list prepared by the study programmer, utilised a permuted, unstratified, block randomisation system (variable size blocks) to achieve an overall ratio of 1:1 control (morphine): intervention (ketamine). Treatment packs were identical in appearance, apart from their unique sequential number. Individual participant randomisation occurred when the attending paramedic opened the treatment pack. The maximum available dose of morphine was 20 mg while the maximum available dose of ketamine was 30 mg. The treating paramedic administered the trial drug slowly, in regular small aliquots, via the intravenous (or intraosseous) route, titrating treatment until the patient reported adequate analgesia or requested that treatment stop due to undesired side effects. Timing of drug administration was not prespecified. The primary outcome was the Sum of Pain Intensity Difference (SPID) score on arrival to the hospital, calculated using patient reported NRS scores. Analysis was performed on an intention to treat basis. PACKMaN is registered with the International Clinical Trials Registry (ISRCTN14124474). Findings: PACKMaN recruited its first patient on 10/11/2021 and achieved its recruitment target on 16/05/2023. We randomised 449 participants: 219 (49%) received ketamine and 230 (51%) received morphine. The SPID score was 3.5 (SD 2.8) for ketamine and 3.4 (SD 3.0) for morphine. We found no significant difference in efficacy between drugs (adjusted mean difference 0.1, 95%CI −0.4 to 0.6, p = 0.74). There was no significant difference in the incidence of serious adverse events [4 (2%) ketamine; 8 (3%) morphine]. There were no treatment related deaths. Interpretation: Ketamine did not provide superior analgesia than morphine when used by paramedics to treat acute severe trauma pain. Unexpected adverse events occurred infrequently. Despite analgesia, many patients still experienced pain on arrival at hospital, highlighting the need for further research. Funding: PACKMaN was funded by the National Institute for Health and Care Research.http://www.sciencedirect.com/science/article/pii/S2666776225000572PainAnalgesiaKetamineMorphineAmbulanceParamedic
spellingShingle Michael A. Smyth
Hannah Noordali
Kath Starr
Joyce Yeung
Ranjit Lall
Felix Michelet
Gordon Fuller
Stavros Petrou
Alison Walker
Zoe Green
Rebecca McLaren
Elisha Miller
Duncan Buckley
Gavin D. Perkins
Paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN): a randomised, double-blind, phase 3 trialResearch in context
The Lancet Regional Health. Europe
Pain
Analgesia
Ketamine
Morphine
Ambulance
Paramedic
title Paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN): a randomised, double-blind, phase 3 trialResearch in context
title_full Paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN): a randomised, double-blind, phase 3 trialResearch in context
title_fullStr Paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN): a randomised, double-blind, phase 3 trialResearch in context
title_full_unstemmed Paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN): a randomised, double-blind, phase 3 trialResearch in context
title_short Paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN): a randomised, double-blind, phase 3 trialResearch in context
title_sort paramedic analgesia comparing ketamine and morphine in trauma packman a randomised double blind phase 3 trialresearch in context
topic Pain
Analgesia
Ketamine
Morphine
Ambulance
Paramedic
url http://www.sciencedirect.com/science/article/pii/S2666776225000572
work_keys_str_mv AT michaelasmyth paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT hannahnoordali paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT kathstarr paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT joyceyeung paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT ranjitlall paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT felixmichelet paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT gordonfuller paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT stavrospetrou paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT alisonwalker paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT zoegreen paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT rebeccamclaren paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT elishamiller paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT duncanbuckley paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext
AT gavindperkins paramedicanalgesiacomparingketamineandmorphineintraumapackmanarandomiseddoubleblindphase3trialresearchincontext